statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy

Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T...

Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology

Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology PR Newswire SAN JOSE, Calif., July 17...

Anixa Biosciences Announces $5 Million Share Repurchase Program

Anixa Biosciences Announces $5 Million Share Repurchase Program Anixa Biosciences Announces $5 Million Share Repurchase Program PR Newswire SAN JOSE, Calif., July 15, 2024 SAN JOSE, Calif., July 15...

Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial PR Newswire SAN JOSE, Calif., June...

Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial PR Newswire...

Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines

Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines PR...

Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja

Anixa Biosciences CEO Featured on 'Target: Cancer Podcast' by Oncologist Dr. Sanjay Juneja Anixa Biosciences CEO Featured on 'Target: Cancer Podcast' by Oncologist Dr. Sanjay Juneja PR Newswire SAN...

Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024

Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024 Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024 PR...

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business...

Anixa Biosciences (ANIX, $3.69) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 15, 2024

This is a Bullish indicator signaling ANIX's price could rise from here. Traders may explore going long the stock or buying call options...

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics, and Other. The CAR-T Therapeutics segment involves the development of immuno-therapy drugs against cancer. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.

Volume	141,747.00
52-Wk High	$5.13
52-Wk Low	$2.15

ANIX Anixa Biosciences Inc

About

Feed

News

Earnings

Fundamentals